Bacopoulos Nicholas G 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed May 24, 2012
Insider Transaction Report
Form 4
Bacopoulos Nicholas G
Director
Transactions
- Award
Option
2012-05-23+25,000→ 25,000 totalExercise: $0.47Exp: 2022-05-23→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]These options are exercisable over a four-year period with 1/48 of the options granted vesting on a monthly basis.
- [F2]These options were granted to Dr. Bacopoulos for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.